Clinical Trials Logo

Blood Pressure, High clinical trials

View clinical trials related to Blood Pressure, High.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01060865 Terminated - Clinical trials for Blood Pressure, High

Evaluation of Aliskiren Efficacy by Different Methods of Blood Pressure Measurements

REALITY
Start date: March 2010
Phase: Phase 4
Study type: Interventional

Almost 50% of hypertensive patients remain uncontrolled. Clinical decisions are mostly based on office blood pressure,despite the fallacies of this method of measurement. Other reasons for not achieving blood pressure targets are lack of 24-hr efficacy and tolerability of existing anti-hypertensive drug classes. Aliskiren (Rasilez®) is a new antihypertensive drug, given once a day. The purpose of the REALITY study-[tREAtment of essentiaL hypertension with rasIlez. evaluation of different methods of blood pressure measurements - efficacy and safeTY evaluation -] is to evaluate the efficacy, and tolerability of aliskiren in a "real life" setting. The efficacy of the drug will be evaluated using 24 hour ambulatory blood pressure monitoring (ABPM). Results will be compared with office, nurse or self blood pressure monitoring. This comparison will allow to decide which follow-up technique is better for those hypertensive patients.